| Literature DB >> 24516584 |
Yi Chen1, Chaohui Yu1, Youming Li1.
Abstract
BACKGROUND: The incidence of esophageal and gastric cancer has been increasing rapidly worldwide in recent years, although the reason for this increase is unclear. Here, a statistical synthesis of studies that evaluated the association between physical activity, a well-known protecting factor against death and other chronic diseases, and the risk of esophageal and gastric cancer was performed.Entities:
Mesh:
Year: 2014 PMID: 24516584 PMCID: PMC3916353 DOI: 10.1371/journal.pone.0088082
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Main characteristics of the studies in the primary meta-analysis that have investigated the association between PA and GC and EC.
| First author, year, subject nationality (reference) | Sex | Study setting | Cancers investigated | Physical activity domain in main result (in subgroup analyses) | Physical activity measurement mode, validity reported, and reliability reported | Confounding effect of age and obesity considered? | Main result RR or OR (95% CI) | Dose-response |
|
| ||||||||
| Brownson, 1991, US (43) | Male | Cancer registry | EC, GC | OCC | Job-title based, no, no | Age: yes Obesity: no | EC: 1.43 (0.66, 3.08) GC: 0.71 (0.45, 1.11) | EC: 0.18 GC: 0.13 |
| Dosemeci, 1993, US (42) | Male | Hospital-based | GC | OCC | Job-title based, yes, no | Age: no Obesity: no | 0.91 (0.54, 1.53) | 0.32 |
| Vigen, 2006, US (39) | Both, separate | Population | EC, GC (cardiac and non-cardiac) | OCC | Job-title based, yes, yes | Age: yes Obesity: yes | Female: EC: 0.35 (0.04, 3.15) GC: 0.69 (0.21, 2.25) Male: EC: 0.77 (0.54, 1.08) GC: 0.79 (0.63,1.00) | EC: 0.07 (combined) GC: cardiac: 0.97 Noncardiac: 0.67(combined) |
| Campbell, 2006, Canada (41) | Both, combined | Population | GC (cardiac and non-cardiac) | REC | Self-administrated, yes, yes | Age: yes Obesity: yes | 0.99 (0.73, 1.34) | 0.40 |
| Chen, 2009, China (45) | Both, combined | Hospital-based | GC (cardiac) | REC | Interview, no, no | Age: yes Obesity: no | 0.58 (0.16, 2.16) | NR |
| Wen, 2010, China (40) | Both, combined | Hospital-based | GC | REC, HH | Interview, no, no | Age: yes Obesity: yes | 0.69 (0.51, 0.99) | 0.04 |
| Parent, 2011, Canada (38) | Male | Population | GC, EC | REC, OCC | Interview, no, no | Age: yes Obesity: yes | EC: 0.54 (0.30, 0.97) GC: 1.09(0.76, 1.54) | NR |
| Etimadi, 2011, Turkey (44) | Both, combined | Hospital-based | EC (ESCC) | OCC | Self-administrated, no, no | Age: yes Obesity: yes | 0.05 (0.01, 0.26) | 0.005 |
|
| ||||||||
| Serverson, 1989, Japan (33) | Both, combined | Population | GC | OCC, REC/HH | Self-administrated, yes, no | Age: yes Obesity: yes | 1.45 (1.07, 1.97) | 0.101 for total PA |
| Wannamethee, 2001, UK (34) | Male | Population | GC | REC | Self-administrated, yes, yes | Age: yes Obesity: yes | 0.60 (0.14, 2.47) | 0.15 |
| Inoue, 2008, Japan (35) | Both, separate | Population | GC | Total physical activity | Self-administrated, yes, yes | Age: yes Obesity: yes | Male: 1.04(0.84, 1.29) Female: 0.63(0.42 0.94) | Men: 0.785 Women: 0.020 |
| Sjodahl, 2008, Norway (32) | Both, combined | Population | GC(cardiac and non-cardiac) | REC | Self-administrated, no, no | Age: yes Obesity: yes | 0.5(0.3, 0.9) | 0.01 |
| Huerta, 2010, Europe (36) | Both, combined | Population | EC (EA), GC (cardiac and non-cardiac, intestinal and diffuse) | OCC, REC | Self-administrated, yes, yes | Age: yes Obesity: yes | GC: 0.69 (0.50, 0.94) EC: 0.98 (0.48, 2.01) | GC: 0.006 EC: 0.951 |
| Leitzmann, 2009, US (30) | Both, combined | Retired Persons | EC (EA and ESCC), GC(cardiac and non-cardiac) | Total physical activity | Self-administrated, no, yes | Age: yes Obesity: yes | GC: 0.84 (0.63, 1.11) EC: 0.71 (0.56, 0.91) | GC: cardiac: 0.147 Noncardiac: 0.024 EC: ESCC: 0.759 EA: 0.240 |
| Yun, 2008, Korea (31) | Male | Population | EC, GC | REC | Self-administrated, yes, yes | Age: yes Obesity: yes | GC: 0.94 (0.86, 0.98) EC: 0.84 (0.66, 1.06) | NR |
* GC = gastric cancer; EC = Esophageal cancer; ESCC = esophageal squamous cell carcinoma; EA = esophageal adenocarcinoma; OCC = occupational physical activity; REC = recreational Physical activity; NR = not reported; HH = household physical activity; OR = odds ratio; RR = relative risk;
Summary of results from the primary meta-analysis and subgroup analysis.
| GC | EC | |||||||
| Meta-analysis | RR(95%CI) | I2, % | P | Within Group ration of results (95% CI) | RR(95%CI) | I2, % | P | Within Group ration of results (95% CI) |
| Primary meta-analysis | 0.87 (0.78, 0.97) | 49.6 | 0.012 | – | 0.73 (0.56, 0.97) | 58.4 | 0.018 | |
| Subgroup analysis | ||||||||
| Study design | ||||||||
| Case-control | 0.84 (0.74, 0.96) | 0 | 0.554 | Reference | 0.55 (0.28, 1.10) | 73.4 | 0.005 | Reference |
| Cohort | 0.87 (0.73, 1.04) | 68.3 | 0.002 | 0.97 (0.78, 1.21) | 0.78 (0.66, 0.92) | 0 | 0.512 | 0.71 (0.35, 1.43) |
| Sex | ||||||||
| Male | 0.91 (0.79, 1.05) | 7.6 | 0.368 | Reference | 0.81 (0.64, 1.02) | 26.8 | 0.251 | Reference |
| Female | 0.64 (0.43, 0.93) | 0 | 0.887 | 1.42 (0.94, 2.13) | 0.35 (0.04, 3.15) | – | – | 2.31 (0.26, 20.8) |
| Risk of bias | ||||||||
| Low | 0.85 (0.71, 1.02) | 61.8 | 0.005 | Reference | 0.79 (0.58,1.08) | 0 | 0.637 | Reference |
| High | 0.90 (0.80, 1.02) | 14.8 | 0.319 | 0.94 (0.76, 1.17) | 0.68 (0.46, 1.02) | 74.8 | 0.003 | 1.16 (0.70, 1.92) |
| Study population | ||||||||
| Europe and America | 0.82 (0.73, 0.92) | 1.9 | 0.421 | Reference | 0.75 (0.62, 0.90) | 2.3 | 0.402 | Reference |
| Asia | 0.93 (0.76, 1.13) | 69.2 | 0.006 | 0.88 (0.70, 1.11) | – | 91.3 | 0.001 | – |
| PA domain | ||||||||
| OCC | 0.79 (0.65, 0.95) | 0 | 0.908 | Reference | – | 78.7 | 0.003 | Reference |
| REC | 0.89 (0.74, 1.06) | 62.8 | 0.006 | 0.89 (0.68, 1.16) | 0.80 (0.63, 1.01) | 8.8 | 0.334 | – |
| Subtype | ||||||||
| Cardiac/EA | 0.78 (0.65, 0.94) | 0 | 0.472 | Reference | 0.79 (0.58, 1.08) | 0 | 0.510 | Reference |
| Noncardiac/ESCC | 0.71 (0.54, 0.94) | 60.0 | 0.028 | 1.10 (0.79, 1.53) | – | 92.0 | 0.000 | – |
* GC = gastric cancer; EC = Esophageal cancer; ESCC = esophageal squamous cell carcinoma; EA = esophageal adenocarcinoma; RR = relative risk.